Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Breast Cancer

  Free Subscription

Articles published in Am J Pathol

Retrieve available abstracts of 14 articles:
HTML format

Single Articles

    June 2024
  1. JANA S, Li W, Lei PJ, Wang Z, et al
    Isolation and Characterization of a Novel Mammary Adenocarcinoma, MCa-P1362, with Hormone Receptor Expression, Human Epidermal Growth Factor Receptor 2 Positivity, and Enrichment in Cancer and Mesenchymal Stem Cells.
    Am J Pathol. 2024;194:1137-1153.
    PubMed     Abstract available

    March 2024
  2. LINSCOTT M, Ren JR, Gestl S, Gunther EJ, et al
    Different oncogenes and reproductive histories shape the progression of distinct premalignant clones in multistage mouse breast cancer models.
    Am J Pathol. 2024 Mar 25:S0002-9440(24)00112.
    PubMed     Abstract available

    December 2023
  3. AYANA G, Lee E, Choe SW
    Vision transformers for breast cancer human epidermal growth factor receptor 2 (HER2) expression staging without immunohistochemical (IHC) staining.
    Am J Pathol. 2023 Dec 12:S0002-9440(23)00460.
    PubMed     Abstract available

  4. MUDENG V, Farid MN, Ayana G, Choe SW, et al
    Domain and Histopathology Adaptations-Based Classification for Malignancy Grading System.
    Am J Pathol. 2023;193:2080-2098.
    PubMed     Abstract available

    November 2023
  5. SONG Q, Muller KE, Hondelink LM, diFlorio-Alexander RM, et al
    Non-Metastatic Axillary Lymph Nodes Have Distinct Morphology and Immunophenotype in Obese Breast Cancer patients at Risk for Metastasis.
    Am J Pathol. 2023 Nov 27:S0002-9440(23)00443.
    PubMed     Abstract available

    September 2023
  6. SAATCHI Y, Schanen P, Cheung RA, Petty HR, et al
    Computer Vision Identifies Recurrent and Nonrecurrent Ductal Carcinoma in Situ Lesions with Special Emphasis on African-American Women.
    Am J Pathol. 2023;193:1195-1207.
    PubMed     Abstract available

  7. WU K, Li W, Liu H, Niu C, et al
    Metabolome Sequencing Reveals that Protein Arginine-N-Methyltransferase 1 Promotes the Progression of Invasive Micropapillary Carcinoma of the Breast and Predicts a Poor Prognosis.
    Am J Pathol. 2023;193:1267-1283.
    PubMed     Abstract available

    April 2023
  8. LI X, Zhang K, Hu Y, Luo N, et al
    YTHDF2 Regulates Cell Growth and Cycle by Facilitating KDM1A mRNA Stability.
    Am J Pathol. 2023;193:442-455.
    PubMed     Abstract available

    February 2023
  9. WU Y, Huang J, Chen H, Tao H, et al
    Tumor-derived oxidative stress triggers ovarian follicle loss in breast cancer.
    Am J Pathol. 2023 Feb 17:S0002-9440(23)00048.
    PubMed     Abstract available

    January 2023
  10. FURTH PA, Wang W, Kang K, Rooney BL, et al
    Overexpression of Estrogen Receptor alpha in Mammary Glands of Aging Mice Is Associated with a Proliferative Risk Signature and Generation of Estrogen Receptor alpha-Positive Mammary Adenocarcinomas.
    Am J Pathol. 2023;193:103-120.
    PubMed     Abstract available

    December 2022
  11. SU A, Yao K, Zhang H, Wang Y, et al
    DANCR induces cisplatin resistance of triple-negative breast cancer by KLF5/ p27 signaling.
    Am J Pathol. 2022 Dec 9:S0002-9440(22)00393-5. doi: 10.1016/j.ajpath.2022.
    PubMed     Abstract available

    July 2022
  12. WANG X, Wei X, Cao Y, Xing P, et al
    ZNF33A promotes tumor progression and BET inhibitor resistance in triple-negative breast cancer.
    Am J Pathol. 2022 Jul 14. pii: S0002-9440(22)00199.
    PubMed     Abstract available

    February 2022
  13. KACZMAREK E, Pyman B, Nanayakkara J, Tuschl T, et al
    Discriminating Neoplastic from Nonneoplastic Tissues Using an miRNA-Based Deep Cancer Classifier.
    Am J Pathol. 2022;192:344-352.
    PubMed     Abstract available

    January 2022
  14. YANG Z, Zhang C, Liu X, Che N, et al
    SETD5 regulates glycolysis in breast cancer stem-like cells and fuels tumor growth.
    Am J Pathol. 2022 Jan 18. pii: S0002-9440(22)00006.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge.